Yang Jiansong, Jamei Masoud, Yeo Karen Rowland, Tucker Geoffrey T, Rostami-Hodjegan Amin
Simcyp Limited, Blades Enterprise Centre, Sheffield, UK.
Curr Drug Metab. 2007 Oct;8(7):676-84. doi: 10.2174/138920007782109733.
Despite a lower content of many drug metabolising enzymes in the intestinal epithelium compared to the liver (e.g. intestinal CYP3A abundance in the intestine is 1% that of the liver), intestinal metabolic extraction may be similar to or exceed hepatic extraction. Modelling of events on first-pass through the intestine requires attention to the complex interplay between passive permeability, active transport, binding, relevant blood flows and the intrinsic activity and capacity of enzyme systems. We have compared the predictive accuracy of the "well-stirred" gut model with that of the "Q(Gut)" model. The former overpredicts the fraction escaping first-pass gut metabolism; the latter improves the predictions by accounting for interplay between permeability and metabolism.
尽管与肝脏相比,肠上皮中许多药物代谢酶的含量较低(例如,肠道中CYP3A的丰度仅为肝脏的1%),但肠道代谢提取可能与肝脏提取相似或超过肝脏提取。对药物首次通过肠道过程的建模需要关注被动通透性、主动转运、结合、相关血流以及酶系统的内在活性和能力之间的复杂相互作用。我们比较了“充分搅拌”肠道模型和“Q(Gut)”模型的预测准确性。前者高估了逃过肠道首过代谢的部分;后者通过考虑通透性和代谢之间的相互作用改进了预测。